Literature DB >> 10392679

Influence of combined zero-balanced and modified ultrafiltration on the systemic inflammatory response during coronary artery bypass grafting.

P Tassani1, J A Richter, G P Eising, A Barankay, S L Braun, C H Haehnel, P Spaeth, H Schad, H Meisner.   

Abstract

OBJECTIVE: To evaluate whether combined zero-balanced and modified ultrafiltration affects the systemic inflammatory response in coronary artery bypass graft (CABG) patients.
DESIGN: Randomized and controlled.
SETTING: University-affiliated heart center. PARTICIPANTS: Forty-three patients scheduled for elective CABG.
INTERVENTIONS: In the ultrafiltration group (UF group; n = 21), zero-balanced ultrafiltration was performed during rewarming and modified ultrafiltration immediately after the end of cardiopulmonary bypass (CPB). A control group of patients (n = 22) was treated identically to the treatment group except no ultrafiltration process was performed.
MEASUREMENTS AND MAIN RESULTS: Immediately after CPB (ie, after zero-balanced ultrafiltration), and again after the modified ultrafiltration, the concentrations of interleukin-6 and interleukin-8 were significantly less (p < 0.05) in the UF group compared with the control group. Both proinflammatory cytokine levels peaked at 2 and 4 hours after CPB, at which time no difference between the two groups could be observed. The levels of measured anti-inflammatory mediators (interleukin-10 and interleukin-1 receptor antagonist) did not show any difference between the two groups. Intrapulmonary shunt fraction decreased in the course of the modified ultrafiltration from 31% +/- 1.2% to 25% +/- 1.3% (p < 0.01), whereas mean arterial pressure increased (69 +/- 1.8 to 80 +/- 2.8 mmHg; p < 0.01); neither parameter changed in the control group. Time to extubation was shorter in the UF group (6.1 +/- 0.5 v 8.6 +/- 0.7 hours; p < 0.05).
CONCLUSION: It was concluded that the use of ultrafiltration diminished inflammatory response in a very limited time period immediately after CPB and, probably as a consequence, slightly improved clinical parameters.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10392679     DOI: 10.1016/s1053-0770(99)90265-3

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  6 in total

1.  Improved coagulation and blood conservation in the golden hours after cardiopulmonary bypass.

Authors:  Scott R Beckmann; Dee Carlile; Randall C Bissinger; M Burrell; Thomas Winkler; William W Shely
Journal:  J Extra Corpor Technol       Date:  2007-06

2.  A pilot goal-directed perfusion initiative is associated with less acute kidney injury after cardiac surgery.

Authors:  J Trent Magruder; Todd C Crawford; Herbert Lynn Harness; Joshua C Grimm; Alejandro Suarez-Pierre; Chad Wierschke; Jim Biewer; Charles Hogue; Glenn R Whitman; Ashish S Shah; Viachaslau Barodka
Journal:  J Thorac Cardiovasc Surg       Date:  2016-09-19       Impact factor: 5.209

3.  Cryoprecipitate and platelet administration during modified ultrafiltration in children less than 10 kg undergoing cardiac surgery.

Authors:  Brian L Mejak; Richard J Ing; Craig McRobb; W Cory Ellis; D Scott Lawson; Mark D Twite; James Jaggers
Journal:  J Extra Corpor Technol       Date:  2013-06

4.  Effect of hemofiltration filter adsorption on circulating IL-6 levels in septic rats.

Authors:  John A Kellum; Michael K Dishart
Journal:  Crit Care       Date:  2002-06-19       Impact factor: 9.097

5.  High-dose ulinastatin improves postoperative oxygenation in patients undergoing aortic valve surgery with cardiopulmonary bypass: A retrospective study.

Authors:  Ka-Young Rhee; Tae-Yun Sung; Ju Deok Kim; Hyun Kang; Nazri Mohamad; Tae-Yop Kim
Journal:  J Int Med Res       Date:  2018-01-14       Impact factor: 1.671

Review 6.  Basics of cardiopulmonary bypass.

Authors:  Manjula Sarkar; Vishal Prabhu
Journal:  Indian J Anaesth       Date:  2017-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.